Muscle Glucose Metabolism in Chronic Obstructive Pulmonary Disease Patients;Utilización de glucosa en los músculos de pacientes con enfermedad pulmonar obstructiva crónica

Archivos de Bronconeumologia

Volumn 50, Issue 6, 2014, Pages 221-227

  Sancho Muñoz, Antonio ^a   Trampal, Carlos ^c   Pascual, Sergi ^a,b,c   Martínez Llorens, Juana ^a,b,c   Chalela, Roberto ^a   Gea, Joaquim ^a,b,c   Orozco Levi, Mauricio ^a,b,c,d  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c Centro Radiológico Computarizado CRC   (Spain)

^d FUNDACIÓN CARDIOVASCULAR DE COLOMBIA   (Colombia)

Author keywords

Chronic obstructive pulmonary disease; Cu driceps; Diafragma; Diaphragm; Enfermedad pulmonar obstructiva cr nica; Metabolism; Metabolismo; Positron emission tomography; Quadriceps; Tomograf a por emisi n de positrones

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; FLUORINE; GLUCOSE BLOOD LEVEL; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BICEPS BRACHII MUSCLE; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; COSTAL MUSCLE; DIAPHRAGM; GLUCOSE METABOLISM; HUMAN; LUNG FUNCTION; LUNG LESION; QUADRICEPS FEMORIS MUSCLE; RECTUS ABDOMINIS MUSCLE; SKELETAL MUSCLE; AGED; ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DIAGNOSTIC USE; FEMALE; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; MIDDLE AGED; MULTIMODAL IMAGING; RETROSPECTIVE STUDY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPIROMETRY; TISSUE DISTRIBUTION;

AGED; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIAPHRAGM; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; MUSCLE, SKELETAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; RADIOPHARMACEUTICALS; RECTUS ABDOMINIS; RETROSPECTIVE STUDIES; SPIROMETRY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85047697563     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2014.04.003     Document Type: Article

References (40)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) [acceso May 2013]. Disponible en:. http://www.goldcopd.org/.
2. Gea J., Martínez-Llorens J., Barreiro E. Alteraciones nutricionales en la EPOC 2013, [Epub ahead of print]. 10.1016/j.medcli.2013.05.040.
3. Gea J., Agustí A., Roca J. Pathophysiology of muscle dysfunction in COPD. J Appl Physiol 2013, 114:1222-1234.
4. Swallow E.B., Reyes D., Hopkinson N.S., Man W.D., Porcher R., Cetti E.J., et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007, 62:115-120.
5. Schols A.M., Slangen J., Volovics L., Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:1791-1797.
6. Killian K.J., Leblanc P., Martin D.H., Summers E., Jones Nl, Campbell E.J. Exercise capacity and ventilatory, circulatory and symptom limitation in patients whith chronic airflow limitation. Am Rev Respir Dis 1992, 146:935-940.
7. Orozco-Levi M., Gea J. Cambios musculares en la enfermedad pulmonar obstructiva crónica: la teoría de los compartimentos. Arch Bronconeumol 2000, 36:95-102.
8. Sala E., Roca J., Marrades R.M., Alonso J., Gonzalez de Suso J.M., Moreno A., et al. Effect of endurance training on skeletal muscle bioenergetic in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159:1726-1734.
9. Gea J., Pasto M., Carmona M.A., Orozco-Levi M., Palomeque J., Broquetas J. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J 2001, 17:939-945.
10. Barreiro E., de la Puente B., Minguella J., Corominas J.M., Serrano S., Hussain S.N., et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005, 171:1116-1124.
11. Ottenheijm C.A., Heunks L.M., Li Y.P., Jin B., Minnaard R., van Hees H.W., et al. Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 174:997-1002.
12. Wijnhoven J.H., Janssen A.J., van Kuppevelt T.H., Rodenburg R.J., Dekhuijzen P.N. Metabolic capacity of the diaphragm in patients with COPD. Respir Med 2006, 100:1064-1071.
13. Aydin A., Hickeson M., Yu J.Q., Zhuang H., Alavi A. Demonstration of excessive metabolic activity of thoracic and abdominal muscles on FDG-PET in patients with chronic obstructive pulmonary disease. Clin Nucl Med 2005, 30:159-164.
14. Osman M.M., Tran I.T., Muzaffar R., Parkar N., Sachdeva A., Ruppel G.L. Does 18F-FDG uptake by respiratory muscles on PET/CT correlate with chronic obstructive pulmonary disease?. J Nucl Med Technol 2011, 39:252-257.
15. Roca J., Sanchis J., Agusti-Vidal A., Segarra F., Navajas D., Rodriguez-Roisin R., et al. Spirometric reference values from mediterranean population. Bull Eur Physiopathol Respir 1986, 22:217-224.
16. Roca J., Rodríguez-Roisín R., Cobo E., Burgos F., Perez J., Clausen J.L. Single breath carbon monoxide diffusing capacity prediction from a Mediterranean population. Am Rev Respir Dis 1990, 141:1026-1032.
17. Roca J., Burgos F., Barberá J.A., Sunyer J., Rodríguez-Roisín R., Castellsagué J., et al. Prediction equations for plethismografics lung volumes. Respir Med 1998, 92:454-460.
18. Boellaard R., O'Doherty M., Weber W., Mottaghy F., Lonsdale M., Stroobants S., et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2010, 37:181-200.
19. Person C., Louis-Dorr V., Poussier S., Commowick O., Malandain G., Maillard L., et al. Voxel-based quantitative analysis of brain images from 18F-FDG PET with a block-matching algorithm for spatial normalization. Clin Nucl Med 2012, 37:268-273.
20. Donahoe M., Rogers R.M., Wilson D.O., Pennock B.E. Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989, 140:385-391.
21. Levison H., Cherniack R.M. Ventilatory cost of exercise in chronic obstructive pulmonary disease. J Appl Physiol 1968, 25:21-27.
22. Gosselink R., Troosters T., Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996, 153:976-980.
23. Orozco-Levi M., Lloreta J., Minguella J., Serrano S., Broquetas J., Gea J. Injury of the human diaphragm associated with exertion and COPD. Am J Respir Crit Care Med 2001, 164:1734-1739.
24. Barreiro E., Ferrer D., Sanchez F., Minguella J., Marin-Corral J., Martinez-Llorens J., et al. Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD. J Appl Physiol 2011, 111:808-817.
25. Doucet M., Debigare R., Joanisse D.R., Cote C., Leblanc P., Gregoire J., et al. Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD. Eur Respir J 2004, 24:971-979.
26. Levine S., Kaiser L., Leferovich J., Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 1997, 337:1799-1806.
27. Orozco-Levi M., Gea J., Lloreta J., Félez M., Minguella J., Serrano S., et al. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 1999, 13:371-378.
28. Reid W.D., Wiggs B.R., Paré P.D., Pardy R.L. Fiber type and regional differences in oxidative capacity and glycogen content in the hamster diaphragm. Am Rev Respir Dis 1992, 146:1266-1271.
29. Reid W.D., Hards J.M., Wiggs B.R., Wood E.N., Wright P.V., Pardy R.L. Proportions and sizes of muscle fiber types in the hamster diaphragm. Muscle Nerve 1989, 12:108-118.
30. Vogiatzis I., Athanasopoulos D., Habazetti H., Aliverti A., Louvaris Z., Cherouveim E., et al. Intercostal muscle blood flow limitation during exercise in chronic obstructive pulmonary disease. Am J Resp Crit Care Med 2010, 182:1105-1113.
31. Barreiro E., Gea J., Corominas J.M., Hussain S.N. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2003, 29:771-778.
32. Gosker H.R., Hesselink M.K., Duimel H., Ward K.A., Schols A.M. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Eur Respir J 2007, 30:73-79.
33. Gosker H.R., Zeegers M.P., Wouters E.F., Schols A.M. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 2007, 62:944-949.
34. Jobin J., Maltais F., Doyon J.F., LeBlanc P., Simard P.M., Simard A.A., et al. Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J Cardiopulm Rehabil 1998, 18:432-437.
35. Maltais F., LeBlanc P., Whittom F., Simard C., Marquis K., Bélanger M., et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 2000, 55:848-853.
36. Montes de Oca M., Torres S.H., de Sanctis J., Mata A., Hernández N., Tálamo C. Skeletal muscle inflammation and nitric oxide in patients with COPD. Eur Respir J 2005, 26:390-397.
37. Orozco-Levi M., Coronell C., Ramírez-Sarmiento A., Lloreta J., Martínez-Llorens J.M., Gáldiz J.B., et al. Injury of peripheral muscles in smokers with chronic obstructive pulmonary disease. Ultrastruct Pathol 2012, 36:228-238.
38. Hernández N., Orozco-Levi M., Belalcázar V., Pastó M., Minguella J., Broquetas J.M., et al. Dual morphometrical changes of the deltoid muscle in patients with COPD. Respir Physiol Neurobiol 2003, 134:219-229.
39. Grimby G., Goldman M., Mead J. Rib-cage and abdominal volume partitioning during exercise and induced hyperventilation. Scand J Respir Dis Suppl 1971, 77:4-7.
40. Puckree T., Cerny F., Bishop B. Abdominal motor unit activity during respiratory and nonrespiratory tasks. J Appl Physiol 1998, 84:1707-1715.